Background: Some national and international strategies for the detection and prevention of emerging infectious diseases have been established across sectors. The capacity to carry out these tasks varies from country to country, and that remains largely undervalued. The Pasteur Institute of C？te d’Ivoire has created and implemented the capacity of national reference centers to fight against emerging and other infectious diseases. Objective: Show on the one hand the strategies used to develop the National Reference Centers and the IPCI and on the other hand the results obtained by performing these strategies. Method: Datas collection by documentary analysis (published scientific articles and grey literature) was done on Google Scholar, PUBMED and institutional reference documents. The documentary research was carried out to have a better understanding of strategies used to create and develop the NRCs in microbiology of communicable diseases. Results: Seven integrated strategies were launched: 1-training and workforce development; 2-investigation of epidemics or public health events; 3-strengthening laboratory epidemiological research; 4-strengthening surveillance systems; 5-improving communication with partners and stakeholders; 6-building national and international collaborations; and 7-strengthening technical and technological platforms. In two decades, the number of researchers has risen from 10 in 2004 to ninety (90) in 2021, with 12 senior researchers and 32 junior researchers. A number of health service staff had attended a qualifying training course, 27 investigations into outbreaks and other public health events had been carried out, 18 short-term research projects had been launched, major surveillance programs and epidemiological research efforts on vector-borne, food-borne and nosocomial infections had begun, and several scientific manuscripts had been published or were edited in the writting press. Conclusion: The Ivorian experience shows that, with concerted effort, considerable progress can be made in the development and implementation of an infectious disease control program.
References
[1]
Ahmed, S.S., Alp, E., UluKilic, A. and Doganay, M. (2015) Establishing Molecular Microbiology Facilities in Developing Countries. Journal of Infection and Public Health, 8, 513-525. https://doi.org/10.1016/j.jiph.2015.04.029
[2]
Oaks Jr, S.C., Shope, R.E. and Lederberg, J. (1992) Emerging Infections: Microbial Threats to Health in the United States. National Academies Press, Washington DC.
[3]
Petersen, L.R., et al. (2000) Developing National Epidemiologic Capacity to Meet the Challenges of Emerging Infections in Germany. Emerging Infectious Diseases, 6, 576-584.
[4]
Binder, S., Levitt, A.M. and Aguilar, J.R. (1998) Preventing Emerging Infectious Diseases: A Strategy for the 21st Century. US Department of Health and Human Services, Centers for Disease Control and Prevention (CDC).
[5]
MSHP and MESRS (2006) Arreté interministeriel designant la liste des centres nationaux de reference (CNR) de l’institut pasteur de Côte D’ivoire dans le domaine des maladies transmissibles.
Cervical Spine Research Society (CSRS) (2007) Programme d’Appui Stratégique Recherche Scientifique. https://www.csrs.ch/pasres/presentation-pasres.php
[8]
MSHP (2019) Arreté n° ; 0022 MSHP/CAB du 11 mars 2019 portant classification des pathogenes en Côte D’Ivoire.
[9]
Bouagnon, R., et al. (2022) Design and Implementation of Nasopharyngeal Specimen Storage in Straws during the COVID19 Pandemic in Côte D’Ivoire. Journal of Biosecurity and One Health, 1, 43-52. https://doi.org/10.36108/GJOBOH/2202.10.0250
[10]
Bouagnon, R., et al. (2023) Resin Straws: A System to Safely Store Nasopharyngeal Specimens Collected during the COVID-19 Pandemic in Ivory Coast. Scholars Academic Journal of Biosciences, 2, 69-73. https://doi.org/10.36347/sajb.2023.v11i02.005
[11]
Akoua-Koffi, C., et al. (2011) Etats fébriles et dengue3 dans l’agglomération Abidjanaise (Côte D’Ivoire) en 2008. Revue Bio-Africa, 9, 54-61.
[12]
Dagnogo, O. (2018) Polymorphisme des gènes Chloroquine Resistance Transporter (crt), dihydrofolate reductase (dhfr) et Kelch13 propeller (K13 propeller) de Plasmodium falciparum dans la salive et les urines chez le sujet atteint de paludisme. Ph.D. Thesis, Université Félix Houphouët-Boigny, Abidjan. https://theses.hal.science/tel-02358468
[13]
Ehui, B.K., Alain, Y., Abdoulaye, O., Daniel, S., Fayeketté, H. and Dosso, M. (2018) Diagnostic par Polymerase Chain Reaction en temps réel des infections à Mycoplasma genitalium dans les syndromes d’écoulement génitaux chez les hommes à Abidjan. Real-time Polymerase Chain Reaction diagnosis of Mycoplasma genitalium infections in genital discharge syndromes in men in Abidjan. Revue International des Sciences Médicales, 20, 288-292.
[14]
Akoua-Koffi, C., et al. (2007)Aspects épidémiologiques et virologiques des diarrhées dues aux Rotavirus à Abidjan, Côte D’Ivoire (1997-2000). Bulletin de la Société de pathologie exotique, 100, 246-249.
[15]
Kacou-N’douba, A., Blessa Anné, J.C. and Okpo, L.S. (2012) Antimicrobial Resistance of Vibrio Cholerae O1 Isolated during a Cholera Epidemic in 2011 in Dry Season in Cote D’Ivoire. The Journal of Infection in Developing Countries, 6, 595- 597. https://doi.org/10.3855/jidc.2001
[16]
Kadjo, H.A., et al. (2018) Detection of Non-Influenza Viruses in Acute Respiratory Infections in Children under Five-Year-Old in Cote D’Ivoire (January-December 2013). African Journal of Infectious Diseases, 12, 78-88. https://doi.org/10.21010/ajid.v12i2.13
[17]
Sylla, Y., Diane, M.K., Adjogoua, V.E., Kadjo, H. and Dosso, M. (2021) Dengue Outbreaks in Abidjan: Seroprevalence and Cocirculating of Three Serotypes in 2017. Outbreak, Surveillance, Investigation & Response (OSIR) Journal, 14, 94-103. https://doi.org/10.59096/osir.v14i3.262527
[18]
Mateo, M., et al. (2019) Fatal Case of Lassa Fever, Bangolo District, Côte D’Ivoire, 2015. Emerging Infectious Disease, 25, 1753-1756. https://doi.org/10.3201/eid2509.190239
[19]
Adjogoua, E.V., et al. (2021) Geographical Distribution of Ticks Ixodidae in Côte D’Ivoire: Potential Reservoir of the Crimean-Congo Hemorrhagic Fever Virus. Vector-Borne and Zoonotic Diseases, 21, 628-634. https://doi.org/10.1089/vbz.2020.2745
[20]
Adjogoua, E.V., Diaha-Kouame, C.A., Guindo-Coulibaly, N., Diane, M.K., Konan, K. and Dosso, M. (2021) Première détection du virus de la fièvre hémorragique Crimée Congo dans les tiques circulant à Bouaflé, région de la Marahoue, Côte D’Ivoire. Revue Bio-Africa, 25, 51-60.
[21]
Odegue, D.K., et al. (2021) Nasopharyngeal Samples Management Strategy during the COVID-19 Pandemic: Experience of the Pasteur Institute of Côte D’Ivoire (2020). Journal of Scientific Research and Reports, 27, 72-79. https://doi.org/10.9734/jsrr/2021/v27i430380
[22]
Kouao, M.D. and Diaha-Kouame, C.A. (2021) Improvement of the Pre-Analytical Phase of Nasopharyngeal Samples during the COVID 19 Pandemic: Experience of the Institute Pasteur De Côte D’Ivoire in 2020. International Journal of Infectious Diseases, 2, 1-6.
[23]
Haddar, C.H., et al. (2020) Validation of a New Rapid Detection Test for Detection of Neisseria meningitidis A/C/W/X/Y Antigens in Cerebrospinal Fluid. Journal of Clinical Microbiolog, 58, e01699-19. https://doi.org/10.1128/JCM.01699-19
[24]
N’guessan, K., Dosso, M., Nahoua, I., Koffi, M.S. and Kouakou, J. (2008) Primary Resistance to Antituberculosis Drugs: Trends in Cote D’Ivoire from 1995 to 2006. Médecine et Maladies Infectieuses, 38, 231-232. https://doi.org/10.1016/j.medmal.2007.11.004
[25]
Doumbia, M., Kouassi, M.A., Kakou, N.S. and Sevede, D. (2013) Molecular Characterization of Hepatitis B Virus Isolated from Two Groups of Patients at Risk in Côte D’Ivoire. Journal of Microbiology Research and Reviews, 1, 61-66.
[26]
Koffi Affoué, C., et al. (2015) Cytotoxic and Antiviral Activity of Methanolic, Ethanolic and Acetate Extracts of Six Varieties of Capsicum. International Journal of Current Microbiology and Applied Sciences, 4, 76-88.
[27]
Akoua-Koffi, C.G., et al. (2014) Yellow Fever and Dengue Fever Serotype 3 Viruses Cocirculation in Côte D’Ivoire in 2008. African Journal of Pathology and Microbiology, 3, 1-5.
[28]
Solange, N.K.E., et al. (2015) Evaluation of Molecular Detection for Viral Hemorrhagic Infection Cases of Yellow Fever and Dengue Fever in Côte D’Ivoire 2010-2012, West Africa. British Journal of Medicine and Medical Research, 5, 396-403. https://doi.org/10.9734/BJMMR/2015/12582
[29]
N’guessan, K., et al. (2014) Assessment of the Geno Type MTBDRplus Assay for Rifampin and Isoniazid Resistance Detection on Sputum Samples in Cote D’Ivoire. European Journal of Microbiology and Immunology, 4, 166-173. https://doi.org/10.1556/EUJMI-D-14-00014
[30]
N’guessan, K., et al. (2014) Use of Rapid Molecular Test for Multidrug-Resistant Tuberculosis Detection among Relapse Cases in Cote D’Ivoire. The International Journal of Mycobacteriology, 3, 71-75. https://doi.org/10.1016/j.ijmyco.2013.11.003
[31]
N’guessan, K., et al. (2016) Rapid Detection of Mycobacterium Tuberculosis Complex in Sputum Samples Using PURE TB-LAMP Assay. The International Journal of Mycobacteriology, 5, S164-S165. https://doi.org/10.1016/j.ijmyco.2016.09.025
[32]
Kadjo, H.A., et al. (2018) Epidemiology of Rubella Infection and Genotyping of Rubella Virus in Cote D’Ivoire, 2012-2016. Journal of Medical Virology, 90, 1687-1694. https://doi.org/10.1002/jmv.25252
[33]
Yéo, A., et al. (2019) Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance with World Health Organization Standards, in Côte D’Ivoire, Western Africa, 2014-2017. Sexually Transmitted Diseases, 46, 179-184. https://doi.org/10.1097/OLQ.0000000000000943
[34]
Goualié, B.G., Akpa, E.E., Kakou-N’Gazoa, S.E., Ouattara, H.G., Niamke, S.L. and Dosso, M. (2019) Antimicrobial Resistance and Virulence Associated Genes in Campylobacter Jejuni Isolated from Chicken in Côte D’Ivoire. The Journal of Infection in Developing Countries, 13, 671-677. https://doi.org/10.3855/jidc.11355
[35]
Sévédé, D., Doumbia, M., Kouakou, V., Djehiffe, V., Pineau, P. and Dosso, M. (2019) Increased Liver Injury in Patients with Chronic Hepatitis and IgG Directed against Hepatitis E Virus. EXCLI Journal, 18, 955-961.
[36]
Doumbia, M., et al. (2021) Viral and Bacterial Factors of Mother-to-Child Transmission of Hepatitis B Virus. Journal of Viral Hepatitis, 28, 1683-1689. https://doi.org/10.1111/jvh.13607
